ArticleACS chemical neuroscience2019

Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.

Bethany A Falls et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.